OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-ADAM17 antibodies

Anti-ADAM17 Antibody

div

Specifications Citations Related Products Product Documents
SKU Description Amount Price Availability*  
TA314586
  • Rabbit polyclonal anti-ADAM 17 antibody
100ul 325 3 Weeks
Add to Shopping Cart
IF(1)

OriGene Data

ImmunogenThe antiserum was produced against synthesized peptide derived from Internal of human ADAM 17.
Clone Name IsotypeIgG
Species ReactivityHuman, Mouse, Rat Concentration1mg/ml
Guaranteed Application *IF Suggested DilutionsIF: 1:100~1:500, ELISA: 1:1000
BufferPhosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Note ADAM 17 antibody detects endogenous levels of total ADAM 17 protein.

Reference Data

Target NameHomo sapiens ADAM metallopeptidase domain 17 (ADAM17)
Alternative NameADAM18; CD156B; CSVP; NISBD; TACE
Database LinkNP_003174
Function
Related Pathway
Delta-Notch Signaling Pathway

* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

IF Image
Immunofluorescence analysis of NIH/3T3 cells, using ADAM 17 antibody.The picture on the right is treated with the synthesized peptide.

 

spacer
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title